Renaissance Technologies (RenTech)'s ANGO Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 803,283 shares of AngioDynamics, Inc. (ANGO) worth $9.13 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in ANGO, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2024, adding 274,431 shares. Largest reduction occurred in Q4 2020, reducing 225,700 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s AngioDynamics (ANGO) Holding Value Over Time
Track share changes against reported price movement
Quarterly AngioDynamics (ANGO) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -39,800 | Reduce 4.72% | 803,283 | $11.37 |
| Q4 2025 | -90,300 | Reduce 9.67% | 843,083 | $12.84 |
| Q3 2025 | -129,346 | Reduce 12.17% | 933,383 | $11.17 |
| Q2 2025 | +166,800 | Add 18.62% | 1.06 M | $9.92 |
| Q1 2025 | -17,100 | Reduce 1.87% | 895,929 | $9.39 |
| Q4 2024 | -143,785 | Reduce 13.61% | 913,029 | $9.16 |
| Q3 2024 | -40,800 | Reduce 3.72% | 1.06 M | $7.78 |
| Q2 2024 | -40,900 | Reduce 3.59% | 1.1 M | $6.05 |
| Q1 2024 | +274,431 | Add 31.76% | 1.14 M | $5.87 |
| Q4 2023 | +205,769 | Add 31.26% | 864,083 | $7.84 |
| Q3 2023 | +156,600 | Add 31.21% | 658,314 | $7.31 |
| Q2 2023 | +119,900 | Add 31.40% | 501,714 | $0.01 |
| Q1 2023 | -78,000 | Reduce 16.96% | 381,814 | $0.01 |
| Q4 2022 | +6,800 | Add 1.50% | 459,814 | $0.01 |
| Q3 2022 | -43,100 | Reduce 8.69% | 453,014 | $20.46 |
| Q2 2022 | +27,500 | Add 5.87% | 496,114 | $19.35 |
| Q1 2022 | -64,500 | Reduce 12.10% | 468,614 | $21.54 |
| Q4 2021 | -40,800 | Reduce 7.11% | 533,114 | $27.58 |
| Q3 2021 | +71,146 | Add 14.15% | 573,914 | $25.94 |
| Q2 2021 | -48,600 | Reduce 8.81% | 502,768 | $27.13 |
| Q1 2021 | -207,546 | Reduce 27.35% | 551,368 | $23.40 |
| Q4 2020 | -225,700 | Reduce 22.92% | 758,914 | $15.33 |
| Q3 2020 | +157,933 | Add 19.10% | 984,614 | $12.06 |
| Q2 2020 | -73,633 | Reduce 8.18% | 826,681 | $10.17 |
| Q1 2020 | +245,100 | Add 37.41% | 900,314 | $10.43 |
| Q4 2019 | +149,268 | Add 29.50% | 655,214 | $16.01 |
| Q3 2019 | +124,600 | Add 32.67% | 505,946 | $18.42 |
| Q2 2019 | -114,600 | Reduce 23.11% | 381,346 | $19.69 |
| Q1 2019 | -84,954 | Reduce 14.62% | 495,946 | $22.86 |
| Q4 2018 | -25,500 | Reduce 4.21% | 580,900 | $20.13 |
| Q3 2018 | -41,200 | Reduce 6.36% | 606,400 | $21.74 |
| Q2 2018 | +6,500 | Add 1.01% | 647,600 | $22.24 |
| Q1 2018 | +99,300 | Add 18.33% | 641,100 | $17.25 |
| Q4 2017 | +82,300 | Add 17.91% | 541,800 | $16.63 |
| Q3 2017 | -214,210 | Reduce 31.80% | 459,500 | $17.09 |
| Q2 2017 | +167,510 | Add 33.09% | 673,710 | $16.21 |
| Q1 2017 | -102,446 | Reduce 16.83% | 506,200 | $17.35 |
| Q4 2016 | -17,200 | Reduce 2.75% | 608,646 | $16.87 |
| Q3 2016 | +131,446 | Add 26.59% | 625,846 | $17.54 |
| Q2 2016 | +55,900 | Add 12.75% | 494,400 | $14.37 |
| Q1 2016 | +74,100 | Add 20.33% | 438,500 | $12.29 |
| Q4 2015 | +107,549 | Add 41.87% | 364,400 | $12.14 |
| Q3 2015 | +40,251 | Add 18.58% | 256,851 | $13.19 |
| Q2 2015 | -47,246 | Reduce 17.91% | 216,600 | $16.40 |
| Q1 2015 | -107,700 | Reduce 28.99% | 263,846 | $17.79 |
| Q4 2014 | +218,386 | Add 142.59% | 371,546 | $19.01 |
| Q3 2014 | +61,160 | Add 66.48% | 153,160 | $13.72 |
| Q2 2014 | +24,454 | Add 36.20% | 92,000 | $16.33 |
| Q1 2014 | -118,500 | Reduce 63.69% | 67,546 | $15.75 |
| Q4 2013 | +93,323 | Add 100.65% | 186,046 | $17.16 |
| Q3 2013 | +74,777 | Add 416.68% | 92,723 | $13.20 |
| Q2 2013 | +17,946 | Add 0.00% | 17,946 | $11.26 |
Renaissance Technologies (RenTech)'s AngioDynamics Investment FAQs
Renaissance Technologies (RenTech) first purchased AngioDynamics, Inc. (ANGO) in Q2 2013, acquiring 17,946 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held AngioDynamics, Inc. (ANGO) for 52 quarters since Q2 2013.
Renaissance Technologies (RenTech)'s largest addition to AngioDynamics, Inc. (ANGO) was in Q1 2024, adding 1,138,514 shares worth $6.68 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 803,283 shares of AngioDynamics, Inc. (ANGO), valued at approximately $9.13 M.
As of the Q1 2026 filing, AngioDynamics, Inc. (ANGO) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in AngioDynamics, Inc. (ANGO) was 1,138,514 shares, as reported at the end of Q1 2024.